2 unknown, 1 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow FGFR2 Gene Translocation: new trials by email Literature Review of FGFR2 Gene Translocation trials Research Report on FGFR2 Gene Translocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements Pemigatinib - Intrahepatic Cholangiocarcinoma, FGFR2 Gene Mutation | Phase 2 | Terminated | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2 | 2022-11-11 | 2025-04-13 |
| Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) Data collection and quality of life questionnaire - Cancer, Cancer Metastatic | Unknown | Centre Leon Berard | 500 | 2021-06-22 | 2021-08-02 | |
| REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors RLY-4008 - FGFR2 Amplification, FGFR2 Gene Mutation | Phase 1 / Phase 2 | Completed | Elevar Therapeutics | 490 | 2020-09-02 | 2026-02-27 |
| Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations Pemigatinib, Quality-of-Life Assessment - FGFR1 Gene Amplification, FGFR1 Gene Mutation | Phase 2 | Unknown | Academic and Community Cancer Research United | 14 | 2020-08-31 | 2024-02-21 |
Cholangiocarcinoma (2) · Colorectal Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Neoplasms (3) · Adenocarcinoma (2) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Pathologic Processes (1)
pemigatinib (2) · Data Collection (1)
Academic and Community Cancer Research United (1) · Centre Leon Berard (1) · Elevar Therapeutics (1) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)
Germany (3) · France (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Australia (1) · Austria (1) · Czechia (1) · Denmark (1) · Hong Kong (1) · Poland (1) · Singapore (1) · Slovenia (1)
Kristen K Ciombor (1) · Salah-Eddin Al-Batran, Prof. Dr. (1) · Thorsten Goetze, Prof. Dr. (1)
P30CA015083 (1)